The Investigational New Drug (IND) market is a segment of the drug discovery process that involves the development of new drugs for medical use. It is a complex process that involves the identification of a potential drug target, the synthesis of a drug candidate, and the testing of the drug candidate in preclinical and clinical trials. The IND market is highly regulated by the US Food and Drug Administration (FDA) and other regulatory bodies, and the process of drug discovery is often lengthy and expensive. The IND market is a key component of the drug discovery process, as it provides the necessary data to support the development of new drugs. It is also an important source of revenue for pharmaceutical companies, as the development of new drugs can lead to significant profits. Some companies in the IND market include Pfizer, Merck, GlaxoSmithKline, Novartis, and Johnson & Johnson. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
